Masahiko MoriyamaPresident & Representative Director This is Moriyama from T&D Holdings. Thank you very much for taking the time out of your busy schedules...
This article was written by Follow Vasily Zyryanov is an individual investor and writer.He uses various techniques to find both relatively underpriced equities with...
This article was written by Follow David A. Johnson is founder and principal of Endurance Capital Management, a New Jersey Limited Liability Company. As...
Akoustis Technologies, Inc. (NASDAQ:AKTS) Q4 2023 Earnings Conference Call September 6, 2023 8:00 AM ET Company Participants Tom Sepenzis – Investor Relations Jeff Shealy...
The retirement savings landscape experienced a radical transformation with the enactment of the SECURE Act 2.0 at the end of 2022. This groundbreaking legislation...
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...
Recombinant therapeutic protein developer, Protalix BioTherapeutics, Inc. (NYSE:PLX) reported Q2 2023 revenues of $35.08 million, representing a 300.72% (YoY) increase. It beat Wall Street...